MMMSX | VISVX | MMMSX / VISVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 27 years | - |
Gain YTD | 5.483 | 14.945 | 37% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 3000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 330M | 63B | 1% |
Annual Yield % from dividends | 0.94 | 1.90 | 50% |
Returns for 1 year | 6.74 | 16.18 | 42% |
Returns for 3 years | 5.67 | 20.58 | 28% |
Returns for 5 years | N/A | 52.67 | - |
Returns for 10 years | N/A | 105.07 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EMECX | 10.59 | N/A | N/A |
Ashmore Emerging Markets Equity C | |||
TAGDX | 17.42 | N/A | N/A |
Transamerica Large Growth R6 | |||
CLWFX | 80.00 | -0.23 | -0.29% |
Columbia Large Cap Growth Inst2 | |||
SHPAX | 19.24 | -0.11 | -0.57% |
Saratoga Health & Biotechnology A | |||
OAKEX | 18.18 | -0.21 | -1.14% |
Oakmark International Small Cap Investor |